Mon, July 23, 2018
Fri, July 20, 2018
Thu, July 19, 2018
Wed, July 18, 2018

Alethia Young Initiated (ANAB) at Buy and Held Target at $104 on, Jul 19th, 2018

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. buy-and-held-target-at-104-on-jul-19th-2018.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Alethia Young of Credit Suisse, Initiated "AnaptysBio, Inc." (ANAB) at Buy and Held Target at $104 on, Jul 19th, 2018.

Alethia has made no other calls on ANAB in the last 4 months.



There are 2 other peers that have a rating on ANAB. Out of the 2 peers that are also analyzing ANAB, 1 agrees with Alethia's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Kennen MacKay of "RBC Capital" Downgraded from Buy to Hold on, Wednesday, April 4th, 2018


This is the rating of the analyst that currently disagrees with Alethia


  • Alex Schwartz of "Stifel" Maintained at Strong Buy with Increased Target to $152 on, Tuesday, March 27th, 2018